Shlomo Zohar Sells 5,000 Shares of Delek US (NYSE:DK) Stock

Delek US Holdings, Inc. (NYSE:DK) Director Shlomo Zohar sold 5,000 shares of the stock in a transaction dated Monday, March 9th. The stock was sold at an average price of $41.47, for a total value of $207,350.00. Following the sale, the director directly owned 13,989 shares in the company, valued at $580,123.83. This represents a 26.33% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Shlomo Zohar also recently made the following trade(s):

• On Thursday, March 5th, Shlomo Zohar sold 22,029 shares of Delek US stock. The shares were sold at an average price of $44.83, for a total value of $987,560.07.
• On Wednesday, March 4th, Shlomo Zohar sold 7,343 shares of Delek US stock. The shares were sold at an average price of $43.00, for a total transaction of $315,749.00.

Delek US Price Performance

DK stock traded up $1.29 during midday trading on Wednesday, reaching $41.93. The stock had a trading volume of 1,173,254 shares, compared to its average volume of 1,636,608. The company has a current ratio of 0.82, a quick ratio of 0.53 and a debt-to-equity ratio of 5.89. The company’s fifty day simple moving average is $33.04 and its 200 day simple moving average is $33.73. The company has a market cap of $2.52 billion, a price-to-earnings ratio of -119.79, a price-to-earnings-growth ratio of 4.93 and a beta of 0.75. Delek US Holdings, Inc. has a 52-week low of $11.02 and a 52-week high of $45.74.

Delek US (NYSE:DK) last issued its earnings results on Friday, February 27th. The oil and gas company reported $0.44 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.19) by $0.63. Delek US had a negative return on equity of 13.55% and a negative net margin of 0.21%.The business had revenue of $2.43 billion during the quarter, compared to the consensus estimate of $2.55 billion. During the same period last year, the company earned ($2.54) EPS. The company’s revenue for the quarter was up 2.3% on a year-over-year basis. As a group, sell-side analysts predict that Delek US Holdings, Inc. will post -5.5 earnings per share for the current fiscal year.

Delek US Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, March 9th. Shareholders of record on Monday, March 2nd were given a $0.255 dividend. This represents a $1.02 annualized dividend and a yield of 2.4%. The ex-dividend date of this dividend was Monday, March 2nd. Delek US’s dividend payout ratio (DPR) is currently -291.43%.

Analyst Ratings Changes

A number of research analysts have commented on the stock. Weiss Ratings restated a “sell (d-)” rating on shares of Delek US in a research note on Wednesday, January 21st. Mizuho increased their price objective on shares of Delek US from $45.00 to $51.00 and gave the company an “outperform” rating in a research note on Friday, December 12th. TD Cowen lifted their price target on shares of Delek US from $28.00 to $44.00 and gave the stock a “hold” rating in a report on Thursday, March 5th. Wall Street Zen upgraded Delek US from a “hold” rating to a “buy” rating in a report on Saturday. Finally, UBS Group raised their target price on shares of Delek US from $31.00 to $42.00 and gave the company a “neutral” rating in a research note on Tuesday, November 18th. Four investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, Delek US currently has a consensus rating of “Hold” and an average price target of $39.46.

Hedge Funds Weigh In On Delek US

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. ION Fund Management Ltd purchased a new stake in shares of Delek US during the fourth quarter worth $52,427,000. Norges Bank acquired a new position in Delek US in the 4th quarter worth about $48,374,000. Arrowstreet Capital Limited Partnership increased its position in Delek US by 6,300.8% in the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 1,306,269 shares of the oil and gas company’s stock worth $42,153,000 after purchasing an additional 1,285,861 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its holdings in shares of Delek US by 1,516.7% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 996,059 shares of the oil and gas company’s stock valued at $29,544,000 after buying an additional 934,448 shares during the last quarter. Finally, Healthcare of Ontario Pension Plan Trust Fund lifted its holdings in shares of Delek US by 1,173.2% during the 4th quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 954,900 shares of the oil and gas company’s stock valued at $28,322,000 after buying an additional 879,900 shares during the last quarter. Institutional investors and hedge funds own 97.01% of the company’s stock.

Delek US Company Profile

Delek US Holdings, Inc (NYSE: DK) is an independent downstream energy company engaged in the refining, logistics, and marketing of petroleum products. Headquartered in Brentwood, Tennessee, the company operates a network of inland refineries, storage terminals and pipelines, and convenience store locations. Delek US focuses on converting crude oil into a variety of finished products, including gasoline, diesel, jet fuel, asphalt and renewable fuels, serving wholesale and retail customers across the United States.

In its refining segment, Delek US owns and operates four inland refineries located in Texas and Arkansas.